A preclinical study led by Monash University has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer called hepatocellular carcinoma (HCC).
The study's lead author, Professor Mark Febbraio from MIPS, said this is an exciting discovery for a particularly widespread and devastating disease with a low survival rate.
, especially metabolic dysfunction-associated fatty liver disease . Globally, a staggering 25 percent of the population are estimated to be living with MAFLD, with around 15% of those exhibiting signs of NASH.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
University of Bolton applies to become University of Greater ManchesterThe University of Bolton applies to change its name in a bid to improve 'graduate outcomes'.
Read more »
Apple Watch Series 9 gets striking new Pink colour as price confirmedThe new Watch is going to be launched this month with a new colour
Read more »
University of Kentucky's cardiovascular scientist recognized for excellence in hypertension researchThe University of Kentucky's Vice President for Research and leading cardiovascular scientist is being recognized for her foundational work in the field of hypertension with a prestigious award from the American Heart Association (AHA).
Read more »
Martin Lewis gives finance advice to students going back to universityThanks Martin!
Read more »
West Lothian College continues partnership with Edinburgh Napier UniversityThe two institutions have agreed a further five-year collaboration agreement.
Read more »